Abstract:
본 발명은 신규한 아미노퀴나졸린 유도체에 관한 것으로, 구체적으로 모핵 구조는 2-아미노퀴나졸린의 8번위치가 피페리딘 4-옥시로 치환되고 2-아미노 기가 6-인다졸로 치환된 화학식 1의 모핵 구조를 가지는 신규한 아미노퀴나졸린 화합물에 관한 것이다. 이러한 화합물은 세포외 신호조절 키나제 1/2(ERK 1/2)의 활성을 효과적으로 저해할 수 있어, 세포 증식이 제어되지 않는 암의 예방 및/또는 치료에 효과적으로 이용될 수 있다.
Abstract:
본 발명은 항균활성을 갖는 신규한 이중고리를 포함하는 옥사졸리디논 유도체 또는 이의 약학적으로 허용 가능한 염, 이들의 제조방법, 및 상기 옥사졸리디논 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 항균 조성물에 관한 것으로서, 본 발명의 옥사졸리디논 유도체 또는 이의 약학적으로 허용 가능한 염은 다양한 내성 균주를 포함하는 그람 양성균에 대하여 우수한 항균 활성을 나타낸다.
Abstract:
PURPOSE: A stride estimating device and a method thereof are provided to easily estimate different strides by using various sensors, thereby enabling to estimate travelling time and to grasp a travelling path. CONSTITUTION: A stride estimating device comprises a vibration detecting sensor(130), a rotation detecting sensor(140), a database unit(180), a travelling distance measuring unit(160), a step number calculation module, a stride estimation module(170), and a control unit(150). The vibration detecting sensor detects vibration information based on a walk of a user. The rotation detecting sensor detects rotation information based on the walk of the user. The database unit stores geographic information. The travelling distance measuring unit measures a travelling distance of the user by using the geographic information and the rotation information. The step number calculation module calculates the number of the steps of the user. The stride estimation module estimates stride of the user by using the calculated the number of the steps and the measured travelling distance. [Reference numerals] (100) User terminal; (120) Communication unit; (130) Vibration detecting sensor; (140) Rotation detecting sensor; (150) Control unit; (160) Travelling distance measuring unit; (170) Stride estimation module; (180) Database unit; (184) Map information database
Abstract:
PURPOSE: An antibacterial agent containing novel diphenyl derivative or pharmaceutically acceptable salt thereof is provided to suppress bacterial fatty acid biosynthesis. CONSTITUTION: An antibacerial agent against mycobacteria contains a compound of chemical formula I or pharmaceutically acceptable salt thereof as an active ingredient. The mycobacteria are Mycobacterium tuberculosis. A composition for preventing or treating mycobacterium infections contains the compound or salt as an active ingredient. The mycobacterium infections are tuberculosis. The composition is manufactured in the form of a pharmaceutical composition administered to mammals and birds.
Abstract:
본 발명은 칼슘이온 채널 조절제로서 유효한 신규 이미다졸릴알킬카르보닐 유도체와 이의 제조방법 및 이 화합물이 갖는 칼슘이온 채널 억제 효과에 의한 질환 치료제로 사용하는 의약적 용도에 관한 것이다. 이미다졸릴알킬카르보닐 유도체, 칼슘이온 채널 조절제, 뉴런, 탈분극화, 급성통증, 만성통증, 신경병증성 통증, 고혈압치료제.
Abstract:
PURPOSE: A novel benzoarylureido compound is provided to prevent the degeneration and damage of brain cells caused by beta-amyloid and to prevent or treat a neurodegenerative disorder. CONSTITUTION: A novel benzoarylureido compound has a structure of chemical formula 1. A composition for preventing or treating a neurodegenerative disorder contains a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient. The composition is used in the form of a tablet, injection, capsule, or pill. A health food for preventing or treating a neurodegenerative disorder contains a compound of chemical formula 1 or a pharmaceutically acceptable salt as an active ingredient.
Abstract:
본 발명은 형광편광도를 이용한 파네소이드 X 수용체-리간드 복합체의 상호작용 분석방법 및 결합저해물질 검색방법에 관한 것으로서, 구체적으로 형광편광도를 이용한 파네소이드 X 수용체 (FXR)와 형광표지된 리간드간의 상호작용 분석방법 및 형광표지된 리간드와 파네소이드 X 수용체를 포함한 시료에 결합저해 후보물질을 가하고, 형광편광도를 측정하여 파네소이드 X 수용체에 대한 리간드와 결합저해 후보물질의 경쟁적 결합여부를 확인함으로써 파네소이드 X 수용체와 리간드 복합체의 결합 저해물질 검색방법에 관한 것이다. 본 발명의 상호작용 분석방법 및 결합 저해물질 검색방법은 웰 플레이트를 이용한 초고속 검색에 효과적으로 적용될 수 있어서 고지혈증 치료제 개발에 매우 유용하다. 파네소이드 X 수용체, 형광편광도, 리간드
Abstract:
A modified 5-AMP(adenine monophosphate)-activated protein kinase(AMPK), a method for preparing the same protein kinase, and use thereof are provided to confer the water-soluble and crystalline structure which is more easily analyzed in the three-dimensional structure analysis on the protein kinase, so that the modified protein kinase acts as a target protein of obesity treatment. The method for preparing the modified water-soluble and crystalline 5-AMP-activated protein kinase comprises the steps of: (i) preparing water-soluble modified AMPK protein wherein a preserved protein kinase active domain of AMPK alpha subunit having the amino acid sequence of SEQ ID NO:1 is contained, and one polypeptide molecule selected from 1-12 amino acid sequences from the N-terminal region is deleted, one polypeptide molecule selected from 250-280 amino acid sequences from the C-terminal region is deleted, or both the polypeptide molecules are deleted; and (ii) crystallizing the modified AMPK protein by performing a hanging-drop vapour diffusion method using water tank solution containing a precipitating agent selected from ammonium sulfate and MES(Methyl ester sulfonate) at 16-26 deg.C and pH 6.0-6.5.
Abstract translation:提供了修饰的5-AMP(腺嘌呤单磷酸)激活的蛋白激酶(AMPK),制备相同蛋白激酶的方法及其用途,以赋予在三维中更容易分析的水溶性和晶体结构 对蛋白激酶进行结构分析,使修饰的蛋白激酶作为肥胖治疗的靶蛋白。 制备修饰的水溶性和结晶5-AMP活化蛋白激酶的方法包括以下步骤:(i)制备水溶性修饰的AMPK蛋白,其中AMPKα亚基的保守蛋白激酶活性结构域具有氨基酸序列 含有SEQ ID NO:1,并且选自N末端区域的1-12个氨基酸序列中的一个多肽分子缺失,选自C末端区域的250-280个氨基酸序列中的一个多肽分子缺失,或者 多肽分子都被删除; (ii)通过使用含有选自硫酸铵和MES(甲基酯磺酸盐)的沉淀剂的水罐溶液在16-26℃和pH 6.0-6.5下进行悬滴蒸气扩散方法使修饰的AMPK蛋白质结晶。
Abstract:
PURPOSE: Provided are an mmunostrip paper for the simultaneous detection of philopon and cannabis without involving additional reagents. CONSTITUTION: The mmunostrip paper for the simultaneous detection of philopon and cannabis comprises the parts of: (i) a sample membrane(1) coated with protein and sugar; (ii) a glass fiber membrane(2) positioned under the sample membrane(1) and containing a drug antibody-colored minute particle complex; (iii) a polyester supporting nitrocellulose membrane(3) connected vertically to the glass fiber membrane(2), and containing a test resulting line as a drug-protein complex and a test controlling line as a second antibodies of the drugs in different sites; (iv) a reaction solution absorbing membrane(4) connected vertically to the polyester supporting nitrocellulose membrane(3); and supporting bars positioned under each membrane, wherein the sugar is dextran; the protein is bovine serum albumin; the colored minute particle is colloidal; and the supporting bar is made of polyester resin.